Enhanced vascular activity of endogenous endothelin-1 in obese hypertensive patients

被引:123
作者
Cardillo, C
Campia, U
Iantorno, M
Panza, JA
机构
[1] Washington Hosp Ctr, Washington, DC 20010 USA
[2] NHLBI, Bethesda, MD 20892 USA
[3] Univ Cattolica Sacro Cuore, Rome, Italy
关键词
endothelin; hypertension; obesity; vasculature; atherosclerosis;
D O I
10.1161/01.HYP.0000103868.45064.81
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Hypertensive patients have increased endothelin-1-dependent vasoconstrictor tone. This abnormality, however, might not be uniformly present in all forms of hypertension, as suggested by experimental studies showing that endothelin-1 activity is enhanced predominantly in low-renin, high-volume models and in insulin-resistant states. Because hypertension in obesity is commonly associated with both expanded plasma volume and insulin resistance, this study sought to determine whether increased body mass index (BMI) in hypertensive patients relates to activation of the endothelin-1 system. Forearm blood flow (FBF) responses ( plethysmography) to intra-arterial infusion of an ETA receptor blocker (BQ-123) were analyzed in hypertensive patients and normotensive control subjects according to BMI. The vasodilator response to BQ-123 was significantly higher in hypertensive patients than in control subjects (P<0.001). During BQ-123, a significant increase in FBF from baseline was observed in obese (BMI≥30 kg/m(2); P<0.001) and overweight (BMI, 27 to 29.9 kg/m(2); P=0.04) but not in lean (BMI<27 kg/m(2); P=0.83) hypertensive patients. In contrast, no significant change in FBF was observed during BQ-123 either in obese (P=0.53), overweight (P=0.76), or lean (P=0.93) normotensive subjects. Moreover, a significant correlation between BMI and the vasodilator response to ETA blockade was observed in hypertensive subjects (R=0.53; P=0.005) but not in control subjects (R=0.11; P=0.58). In human hypertension, increased BMI is associated with enhanced ETA-dependent vasoconstrictor activity, suggesting that this abnormality may play a role in the pathophysiology of obesity-related hypertension and that targeting the endothelin-1 system may be useful in the treatment of these patients.
引用
收藏
页码:36 / 40
页数:5
相关论文
共 26 条
[1]   INSULIN INFLUENCES IMMUNOREACTIVE ENDOTHELIN RELEASE BY HUMAN VASCULAR SMOOTH-MUSCLE CELLS [J].
ANFOSSI, G ;
CAVALOT, F ;
MASSUCCO, P ;
MATTIELLO, L ;
MULARONI, E ;
HAHN, A ;
TROVATI, M .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1993, 42 (09) :1081-1083
[2]   Endothelin-1 gene variant associates with blood pressure in obese Japanese subjects - The Ohasama study [J].
Asai, T ;
Ohkubo, T ;
Katsuya, T ;
Higaki, J ;
Fu, YX ;
Fukuda, M ;
Hozawa, A ;
Matsubara, M ;
Kitaoka, H ;
Tsuji, I ;
Araki, T ;
Satoh, H ;
Hisamichi, S ;
Imai, Y ;
Ogihara, T .
HYPERTENSION, 2001, 38 (06) :1321-1324
[3]   Role of endothelin in the increased vascular tone of patients with essential hypertension [J].
Cardillo, C ;
Kilcoyne, CM ;
Waclawiw, M ;
Cannon, RO ;
Panza, JA .
HYPERTENSION, 1999, 33 (02) :753-758
[4]   Improved endothelium-dependent vasodilation after blockade of endothelin receptors in patients with essential hypertension [J].
Cardillo, C ;
Campia, U ;
Kilcoyne, CM ;
Bryant, MB ;
Panza, JA .
CIRCULATION, 2002, 105 (04) :452-456
[5]   Insulin stimulates both endothelin and nitric oxide activity in the human forearm [J].
Cardillo, C ;
Nambi, SS ;
Kilcoyne, CM ;
Choucair, WK ;
Katz, A ;
Quon, MJ ;
Panza, JA .
CIRCULATION, 1999, 100 (08) :820-825
[6]   Endothelin antagonists in salt-dependent hypertension associated with renal insufficiency [J].
Doucet, J ;
Gonzalez, W ;
Michel, JB .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1996, 27 (05) :643-651
[7]   INSULIN STIMULATES ENDOTHELIN-1 SECRETION FROM HUMAN ENDOTHELIAL-CELLS AND MODULATES ITS CIRCULATING LEVELS IN-VIVO [J].
FERRI, C ;
PITTONI, V ;
PICCOLI, A ;
LAURENTI, O ;
CASSONE, MR ;
BELLINI, C ;
PROPERZI, G ;
VALESINI, G ;
DEMATTIA, G ;
SANTUCCI, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (03) :829-835
[8]   Salt-sensitive hypertension in endothelin-B receptor-deficient rats [J].
Gariepy, CE ;
Ohuchi, T ;
Williams, SC ;
Richardson, JA ;
Yanagisawa, M .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (07) :925-933
[9]   Mechanisms of hypertension and kidney disease in obesity [J].
Hall, JE ;
Brands, MW ;
Henegar, JR .
THE METABOLIC SYNDROME X: CONVERGENCE OF INSULIN RESISTANCE, GLUCOSE INTOLERANCE, HYPERTENSION, OBESITY, AND DYSLIPIDEMIAS-SEARCHING FOR THE UNDERLYING DEFECTS, 1999, 892 :91-107
[10]   CONTRIBUTION OF ENDOGENOUS GENERATION OF ENDOTHELIN-1 TO BASAL VASCULAR TONE [J].
HAYNES, WG ;
WEBB, DJ .
LANCET, 1994, 344 (8926) :852-854